The Massachusetts Institute of Technology has received a $100-million donation for a new cancer-research center from an alumnus who is a prostate-cancer survivor, MIT officials announced on Tuesday.

The Massachusetts Institute of Technology has received a $100-million pledge from David H. Koch — an executive vice president of Koch Industries and an alumnus — to build a new cancer-research center.

For people who are at high risk of developing breast cancer, frequent screenings with ultrasound can help detect tumors early. MIT researchers have ...

AT MIT, THEY’RE WORKING ON DODGING ASTEROIDS. MOTHER EARTH RECENTLY DODGED A BULLET. AN ASTEROID THE SIZE OF AN EIGHT STORY BUILDING. BUT WE’RE NOT ENTIRELY IN THE CLEAR. YEAH, THERE MIGHT BE MORE ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing immune cells that could make “off-the-shelf” cancer medications more potent ...

An enduring challenge for the study of human cancer is just how complex it is: how many different ways there are for cancers to originate, progress, and spread in the people who are diagnosed with ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand down. Researchers at MIT and Stanford have now engineered a way to rip away ...

CAMBRIDGE, MA -- Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian cancer. These particles can be targeted directly to tumors, ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we treat hundreds of genetic diseases. By fine-tuning the tiny molecular “tools ...

CAMBRIDGE, MA - A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose. In studies in mice, the researchers showed that an ...

A new study from MIT reveals how cancer cells take some of their first steps away from their original tumor sites. This spread, known as metastasis, is responsible for 90 percent of cancer deaths.